CClinicalTrials.gg
CompletedNCT06590363Updated Sep 19, 2024

The Effect of Music on Anxiety in the Appointment Period

An interventional study of Listening to zen music in Anxiety, sponsored by Centro Hospitalar e Universitário de Coimbra, E.P.E.. Completed at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Centro Hospitalar e Universitário de Coimbra, E.P.E. · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2024, registered Aug 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized clinical trial is to learn if musical intervention can reduce anxiety on patients and doctors in the appointment period. The main questions it aims to answer are:

Can music reduce the psychological symptoms of anxiety at the end of the appointment? Can music reduce heart rate and blood pressure at the end of the appointment?

Researchers will compare if the presence of zen music during the appointment influences anxiety levels.

Participants in the intervention group will listen to music during the appointment. Those in the control group will not have music in the office during the appointment.

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • music
  • anxiety
  • heart rate
  • blood pressure
  • appointment
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 70 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Centro Hospitalar e Universitário de Coimbra, E.P.E. is the lead sponsor of 13 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • scheduled appointment;
  • agree to participate in the clinical trial.

Exclusion criteria

Exclusion Criteria:

  • 17 years or younger;
  • deaf;
  • illiterate.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Music

    Corresponded to patients and doctors subjected to the period of listening to zen music in the appointment.

    Other: Listening to zen music

  • No intervention
    Non-Music

    Corresponded to patients and doctors not subjected to the period of listening to zen music.

Interventions

  • OtherListening to zen music

    We conducted a quasi-randomized controlled clinical trial with two groups: Intervention Group (I), which corresponded to patients and doctors who underwent the period of musical listening in the office; and the Control Group (C), composed of patients and doctors who did not undergo the period of musical listening.

06

What researchers measure

Primary outcomes

  1. Anxiety

    Participants achieved a response if they scored of the State-Trait Anxiety Inventory reduze in the end of the appointment. STAI scores are classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).

    Time frame: 16 weeks

Secondary outcomes

  1. Heart rate

    Participants achieved a response if the heart rate reduze in the end of the appointment

    Time frame: 16 weeks

  2. Blood Pressure

    Participants achieved a response if the systolic and diastolic blood pressure reduze in the end of the appointment

    Time frame: 16 weeks

07

Study locations

1 site
  • Cátia Valesca Nunes Solis
    Coimbra, 3000-317, Portugal
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06590363
Lead sponsor
Centro Hospitalar e Universitário de Coimbra, E.P.E.
Responsible party
Catia Valesca (Principal Investigator, Centro Hospitalar e Universitário de Coimbra, E.P.E.) — Principal investigator
First posted
Sep 19, 2024
Start date
Jan 1, 2024
Primary completion
Apr 14, 2024
Completion
Apr 14, 2024
Last update
Sep 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion